Insulin: clinical trials recruiting now
5
Recruiting trials
11
Conditions studied
2
US states with sites
4
Countries
FDA drug label
- FDA-approved
- Yes. Insulin appears in the FDA drug-label database. Marketed as Insulin 1556.
- Drug class
- Insulin Analog (FDA established pharmacologic class)
FDA-approved use
For the temporary relief of general weakness, debilitation, excessive sweating, or minor skin rash or hives due to sensitivity to phenolic compounds found in foods or other products.*
FDA recalls / enforcement
| Reason (FDA) | Classification | Status | Initiated |
|---|---|---|---|
| CGMP Deviations — Eli Lilly & Company | Class II (FDA: may cause temporary or reversible harm) | Completed | 2024-03-12 |
| Lack of Assurance of Sterility: Malformed crimped collar seal — Sanofi-Aventis U.S. LLC | Class II (FDA: may cause temporary or reversible harm) | Ongoing | 2023-04-11 |
| Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Novo Nordisk Inc | Class I (FDA: reasonable probability of serious harm or death) | Terminated | 2021-03-22 |
| TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather. — Cardinal Health Inc. | Class I (FDA: reasonable probability of serious harm or death) | Completed | 2022-04-05 |
| Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Novo Nordisk Inc | Class I (FDA: reasonable probability of serious harm or death) | Terminated | 2021-03-22 |
Phase breakdown
Early Phase 1 1
Phase 2 1
Phase 4 2
Not applicable 1
Conditions being studied
Recruiting trials involving Insulin
- Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors
- Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
- Insulin Sensitivity After Breast Cancer
- Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
- Regional Lipolysis Insulin Regulation
Common questions
Is Insulin FDA-approved?
Yes, marketed as Insulin 1556.
How many recruiting trials involve Insulin?
5 recruiting trials across 11 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.